Research graph
References from Recent progress in the biomarkers of peripheral artery disease. Local targets link to admitted publications; unresolved targets remain external evidence.
Assessing the prevalence rate of gangrene among patients with peripheral vascular disease in a tertiary care hospital in Central India
2024 · External reference
Medical management for chronic atherosclerotic peripheral arterial disease
10.2165/11640810-000000000-00000 · 2012 · External reference
Peripheral artery disease: molecular mechanisms and novel therapies
10.1161/atvbaha.124.320195 · 2024 · External reference
10.1155/2019/8295054
10.1155/2019/8295054 · External reference
Cost and inpatient burden of peripheral artery disease: findings from the national inpatient sample
10.1016/j.atherosclerosis.2019.05.026 · 2019 · External reference
Forecasting the global burden of peripheral artery disease from 2021 to 2050: a population-based study
2025 · External reference
Serum cfas content correlates with incidence of peripheral arterial disease
2025 · External reference
Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke
10.1177/1747493018778713 · 2018 · External reference
Peripheral vascular disease
10.1016/j.pop.2023.07.005 · 2024 · External reference
Reactive oxygen species and immune regulation
10.1080/08830185.2020.1768251 · 2020 · External reference
Instrumental role for reactive oxygen species in the inflammatory response
10.2741/4848 · 2020 · External reference
Mitochondrial reactive oxygen species drive proinflammatory cytokine production
10.1084/jem.20110367 · 2011 · External reference
A systematic review of interleukins as diagnostic and prognostic biomarkers for peripheral artery disease
10.3390/biom13111640 · 2023 · External reference
Oxidative stress and arterial dysfunction in peripheral artery disease
2018 · External reference
10.1152/japplphysiol.00885.2013
10.1152/japplphysiol.00885.2013 · External reference
Cebpd regulates oxidative stress and inflammatory responses in hypertensive cardiac remodeling
10.1097/shk.0000000000002228 · 2023 · External reference
Branched-chain amino acids promote endothelial dysfunction through increased reactive oxygen species generation and inflammation
10.1111/jcmm.13759 · 2018 · External reference
Endothelial progenitor cell dysfunction in cardiovascular diseases: role of reactive oxygen species and inflammation
10.1155/2013/845037 · 2013 · External reference
Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy
10.1161/01.atv.0000237750.44469.88 · 2006 · External reference
Pathogenesis of atherosclerosis
10.1016/j.jacc.2005.09.068 · 2006 · External reference
Pathogenesis of the limb manifestations and exercise limitations in peripheral artery disease
10.1161/circresaha.116.303566 · 2015 · External reference
Peripheral arterial disease and Virchow’s triad
10.1160/th08-08-0518 · 2009 · External reference
Epidemiology of peripheral artery disease and polyvascular disease
10.1161/circresaha.121.318535 · 2021 · External reference
Exercise training enhances endogenous fibrinolysis in peripheral arterial disease
10.1016/j.jvs.2004.07.030 · 2004 · External reference
Nonatherosclerotic arterial disorders of the lower extremities
10.1161/circulationaha.111.060335 · 2012 · External reference
Nonatherosclerotic PAD: approach to exertional pain in the lower extremities
10.1007/s11886-015-0622-8 · 2015 · External reference
Popliteal artery entrapment syndrome: updates for evaluation, diagnosis, and treatment
10.1249/jsr.0000000000001194 · 2024 · External reference
ACR appropriateness criteria(®) nonatherosclerotic peripheral arterial disease
10.1016/j.jacr.2019.02.026 · 2019 · External reference
One of the most urgent vascular circumstances: acute limb ischemia
10.1177/2050312113516110 · 2013 · External reference
Editor’s choice - European Society for Vascular Surgery (ESVS) 2020 clinical practice guidelines on the management of acute limb ischaemia
10.1016/j.ejvs.2019.09.006 · 2020 · External reference
10.1093/eurheartj/ehae179
10.1093/eurheartj/ehae179 · External reference
interleukin 6 (il-6)
1992 · External reference
Gene of the month: interleukin 6 (il-6)
10.1136/jclinpath-2014-202493 · 2014 · External reference
Cardiovascular biology of interleukin-6
10.2174/138161209788186290 · 2009 · External reference
The biology and medical implications of interleukin-6
10.1158/2326-6066.cir-14-0022 · 2014 · External reference
Plasma levels of inflammatory biomarkers in peripheral arterial disease: results of a cohort study
10.1177/0003319716633339 · 2016 · External reference
Proinflammatory circulating molecules in peripheral arterial disease
2007 · External reference
Interferon gamma and tumor necrosis factor alpha are inflammatory biomarkers for major adverse cardiovascular events in patients with peripheral artery disease
10.3390/biomedicines13071586 · 2025 · External reference
Interleukin-6 and interleukin-10 gene polymorphism, endothelial dysfunction, and postoperative prognosis in patients with peripheral arterial disease
10.1016/j.jvs.2010.01.088 · 2010 · External reference
Neopterin as a potential prognostic and predictive biomarker in metastatic renal cell carcinoma treated with immune checkpoint inhibitors
10.1080/14737140.2024.2341734 · 2024 · External reference
Neopterin as a marker of congenital cytomegalovirus infection
10.1016/j.earlhumdev.2025.106399 · 2025 · External reference
Neopterin: a potential marker in chronic peripheral arterial disease
10.3892/mmr.2013.1407 · 2013 · External reference
Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-st segment elevation acute coronary syndromes
10.1136/hrt.2003.015826 · 2004 · External reference
Assessment of serum neopterin as a biomarker in peripheral artery disease
2021 · External reference
Narrative review of biological markers in chronic limb-threatening ischemia
10.3390/biomedicines12040798 · 2024 · External reference
Biomarker utility for peripheral artery disease diagnosis in real clinical practice: a prospective study
10.3390/diagnostics10090723 · 2020 · External reference
Inflammation during the life cycle of the atherosclerotic plaque
2021 · External reference
Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosis
10.1155/2015/718329 · 2015 · External reference
The significance of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and lymphocyte-monocyte ratio in predicting peripheral arterial disease, peripheral neuropathy, osteomyelitis and amputation in diabetic foot infection
10.1016/j.diabres.2018.08.009 · 2018 · External reference
Neutrophil-to-lymphocyte ratio as a prognostic biomarker in patients with peripheral artery disease: a systematic review and meta-analysis
10.1177/1358863x241281699 · 2024 · External reference
Post-treatment neutrophil-lymphocyte ratio independently predicts amputation in critical limb ischemia without operation
10.6061/clinics/2015(04)09 · 2015 · External reference
An elevated neutrophil-lymphocyte ratio independently predicts mortality in chronic critical limb ischemia
10.1016/j.jvs.2010.03.067 · 2010 · External reference
The inflammatory pattern of chronic limb-threatening ischemia in muscles: the tnf-α hypothesis
10.3390/biomedicines10020489 · 2022 · External reference
The role of inflammation in cardiovascular diseases: the predictive value of neutrophil-lymphocyte ratio as a marker in peripheral arterial disease
10.2147/tcrm.s107635 · 2016 · External reference
Platelets in inflammation and atherogenesis
10.1172/jci27196 · 2005 · External reference
Platelets, inflammation and atherosclerosis
10.1111/j.1538-7836.2007.02517.x · 2007 · External reference
Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein e
10.1038/nm810 · 2003 · External reference
Cd8+ t lymphocytes regulate the arteriogenic response to ischemia by infiltrating the site of collateral vessel development and recruiting cd4+ mononuclear cells through the expression of interleukin-16
10.1161/circulationaha.105.576702 · 2006 · External reference
Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients
2013 · External reference
The role played by novel inflammatory markers in assessment of peripheral artery disease
2023 · External reference
Neutrophil-to-lymphocyte, platelet-to-lymphocyte and lymphocyte-to-monocyte ratios are associated with amputation rates in patients with peripheral arterial disease and diabetes mellitus who underwent revascularization: a Romanian regional center study
10.3892/etm.2022.11639 · 2022 · External reference
High-density lipoproteins during sepsis: from bench to bedside
10.1186/s13054-020-02860-3 · 2020 · External reference
Combination model of neutrophil to high-density lipoprotein ratio and system inflammation response index is more valuable for predicting peripheral arterial disease in type 2 diabetic patients: a cross-sectional study
2023 · External reference
Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility
10.1146/annurev.immunol.23.021704.115756 · 2005 · External reference
Regulation of leukocyte recruitment by the long pentraxin ptx3
10.1038/ni.1854 · 2010 · External reference
Relationship of inflammatory biomarkers with severity of peripheral arterial disease
2016 · External reference
Production of the long pentraxin ptx3 in advanced atherosclerotic plaques
10.1161/01.atv.0000015595.95497.2f · 2002 · External reference
Long pentraxin ptx3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation
10.1161/01.atv.0000012282.39306.64 · 2002 · External reference
Plasma pentraxin 3 may be a better marker of peripheral artery disease in hemodialysis patients than c-reactive protein
10.1177/1358863x13483864 · 2013 · External reference
Plasma pentraxin 3 is closely associated with peripheral arterial disease in hemodialysis patients and predicts clinical outcome: a 6-year follow-up
10.1159/000381254 · 2015 · External reference
Plasma pentraxin 3 levels are associated with carotid imt in type 1 diabetic patients
10.1016/j.diabres.2012.11.020 · 2013 · External reference
Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management
2004 · External reference
The role of vascular adhesion molecules PECAM-1 (CD 31), VCAM-1 (CD 106), E-selectin (CD62e) and P-selectin (CD62p) in severe porcine pancreatitis
2009 · External reference
Increased circulating cd62e(+) endothelial extracellular vesicles predict severity and in- hospital mortality of covid-19 patients
10.1007/s12015-022-10446-5 · 2023 · External reference
Biological variation of established and novel biomarkers for atherosclerosis: results from a prospective, parallel-group cohort study
10.1016/j.cca.2015.05.003 · 2015 · External reference
E-selectin and restenosis after femoropopliteal angioplasty: prognostic impact of the ser128arg genotype and plasma levels
10.1160/th03-06-0402 · 2004 · External reference
Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio
10.1161/atvbaha.110.203364 · 2010 · External reference
Genetic deletion or tweak blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice
10.1111/jcmm.12221 · 2014 · External reference
Cd163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice
10.1096/fj.202000177r · 2020 · External reference
Impact of soluble tweak and cd163/tweak ratio on long-term cardiovascular mortality in patients with peripheral arterial disease
10.1016/j.atherosclerosis.2011.09.016 · 2011 · External reference
Evaluation of scd163 and stweak in patients with stable peripheral arterial disease and association with disease severity as well as long-term mortality
10.1016/j.atherosclerosis.2020.11.026 · 2021 · External reference
The value of growth differentiation factor 15 as a biomarker for peripheral artery disease in diabetes patients
10.1186/s13098-025-01588-w · 2025 · External reference
Investigation of growth differentiation factor 15 as a prognostic biomarker for major adverse limb events in peripheral artery disease
10.3390/jcm14155239 · 2025 · External reference
Growth differentiation factor 15 predicts cardiovascular events in peripheral artery disease
2025 · External reference
Inflammation in peripheral arterial disease (PAD)
10.2174/138161212802481273 · 2012 · External reference
Peripheral artery disease, biomarkers, and darapladib
10.1016/j.ahj.2011.01.017 · 2011 · External reference
Prediction of peripheral artery disease prognosis using clinical and inflammatory biomarker data
10.2147/jir.s471150 · 2024 · External reference
Analysis of novel cardiovascular biomarkers in patients with peripheral artery disease
10.23736/s0026-4806.18.05628-8 · 2018 · External reference
Glyca, a novel inflammatory marker and its association with peripheral arterial disease and carotid plaque: the multi-ethnic study of atherosclerosis
10.1177/0003319719845185 · 2019 · External reference
The nitric oxide system in peripheral artery disease: connection with oxidative stress and biopterins
2020 · External reference
Impaired hemodynamic response to exercise in patients with peripheral artery disease: evidence of a link to inflammation and oxidative stress
2022 · External reference
Impact of endovascular therapy on oxidative stress in patients with peripheral artery disease
10.1253/circj.cj-13-1341 · 2014 · External reference
Superoxide dismutases: role in redox signaling, vascular function, and diseases
10.1089/ars.2011.3999 · 2011 · External reference
Oxidative stress and antioxidant defense mechanisms linked to exercise during cardiopulmonary and metabolic disorders
10.4161/oxim.2.1.7732 · 2009 · External reference
Superoxide dismutase and clopidogrel: A potential role in peripheral arterial disease treatment
10.1134/s1607672924600088 · 2024 · External reference
The imbalance among oxidative biomarkers and antioxidant defense systems in thromboangiitis obliterans (winiwarter-buerger disease)
10.3390/jcm9041036 · 2020 · External reference
Indices of antioxidant system of blood in differential diagnosis of obliterating atherosclerosis and obliterating thromboangiitis of the lower limbs
2007 · External reference
Malondialdehyde (mda) as a lipid peroxidation marker
2004 · External reference
The role of VEGF and TNF-alpha on epithelialization of diabetic foot ulcers after hyperbaric oxygen therapy
10.3889/oamjms.2019.297 · 2019 · External reference
Biomarkers of inflammation, oxidative stress, and endothelial dysfunction in early detection of diabetic foot ulcers
2025 · External reference
Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease
10.2337/dc06-1508 · 2007 · External reference
Lipidomic insights on abdominal aortic aneurysm and peripheral arterial disease
10.1007/s00109-025-02524-1 · 2025 · External reference
Circulating malondialdehyde-modified low-density lipoprotein (mda-ldl) as a novel predictor of clinical outcome after endovascular therapy in patients with peripheral artery disease (pad)
10.1016/j.atherosclerosis.2017.06.029 · 2017 · External reference
Malondialdehyde-modified low-density lipoprotein as a predictor of major adverse limb events after endovascular therapy in patients with lower extremity arterial disease
10.5551/jat.64091 · 2023 · External reference
Immunoglobulin m type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis
10.1161/01.cir.0000092891.55157.a7 · 2003 · External reference
Lipid peroxidation and antioxidant enzymes in coronary and peripheral artery disease
2001 · External reference
Comparison of the oxidative profiles before and after revascularization in peripheral arterial disease: a pilot study
10.3164/jcbn.22-109 · 2023 · External reference
Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease
10.1093/eurheartj/ehl533 · 2007 · External reference
The protective role of heme oxygenase-1 in atherosclerotic diseases
10.3390/ijms20153628 · 2019 · External reference
Plasma heme oxygenase-1 is decreased in peripheral artery disease patients
10.3892/mmr.2016.5644 · 2016 · External reference
Urinary vanin-1 as a novel biomarker for survival in peripheral artery disease
10.1177/1358863x241240428 · 2024 · External reference
Current nanomedicine for targeted vascular disease treatment: trends and perspectives
10.3390/ijms232012397 · 2022 · External reference
Expression of vascular cell adhesion molecule-1 in peripheral artery disease is enriched in patients with advanced kidney disease
2021 · External reference
High circulating levels of cytokines (IL-6 and TNFalpha), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test
10.1191/1358863x03vm466oa · 2003 · External reference
Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease
10.1016/s0021-9150(98)00175-0 · 1999 · External reference
Disease-specific characteristics of vascular cell adhesion molecule-1 levels in patients with peripheral artery disease
10.1007/s00380-018-1315-1 · 2019 · External reference
Adhesion molecules and cardiovascular risk in peripheral arterial disease. Soluble vascular cell adhesion molecule-1 improves risk stratification
10.1160/th04-07-0440 · 2005 · External reference
Von willebrand factor, von willebrand factor-cleaving protease, and shear stress
10.2174/187152507782109863 · 2007 · External reference
Von willebrand factor processing
10.5482/hamo-16-06-0018 · 2017 · External reference
Evaluation of plasma biomarkers for causal association with peripheral artery disease
10.1161/atvbaha.124.320674 · 2024 · External reference
Coagulation factor activity and hemostatic markers of endothelial dysfunction in patients with peripheral arterial disease
10.5758/vsi.210010 · 2021 · External reference
Role of von willebrand factor in vascular disease
10.1055/s-0037-1616936 · 2009 · External reference
Effects of percutaneous lower-extremity arterial interventions on endothelial function and inflammation response in patients with both type 2 diabetes and lower-extremity peripheral arterial disease
2015 · External reference
Matrix metalloproteinases 7 and 10 are prognostic biomarkers for systemic cardiovascular risk in individuals with peripheral artery disease
2025 · External reference
Endothelin-1 and its role in cancer and potential therapeutic opportunities
10.3390/biomedicines12030511 · 2024 · External reference
Short communications: Endothelin-1 in cardiac allograft vasculopathy
10.1016/j.mvr.2024.104751 · 2025 · External reference
Predictive value of p-selectin and endothelin-1 for vascular restenosis after interventional procedures for peripheral artery disease
2019 · External reference
Vascular-1 and vascular-2 as a new potential angiogenesis and endothelial dysfunction markers in peripheral arterial disease
10.1177/1076029619877440 · 2019 · External reference
Adiponectin and adiponectin receptors in atherosclerosis
10.1210/endrev/bnae021 · 2025 · External reference
Adiponectin and cardiovascular disease
10.1253/circj.cj-09-0057 · 2009 · External reference
The clinical implications of blood adiponectin in cardiometabolic disorders
10.1016/s0929-6646(09)60079-6 · 2009 · External reference
Hypoadiponectinemia is associated with symptomatic atherosclerotic peripheral arterial disease
10.1515/cclm.2006.145 · 2006 · External reference
Adiponectin and inflammatory markers in peripheral arterial occlusive disease
10.1016/j.atherosclerosis.2005.10.039 · 2006 · External reference
Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: results from the Linz peripheral arterial disease (lipad) study
10.1016/j.cca.2009.07.014 · 2009 · External reference
Association of adiponectin and amino terminal probnp in peripheral arterial disease
10.1016/j.cca.2006.09.022 · 2007 · External reference
Osteoprotegerin plasma concentrations correlate with severity of peripheral artery disease
10.1016/j.atherosclerosis.2005.01.042 · 2005 · External reference
Pathophysiological roles of osteoprotegerin (opg)
10.1016/j.ejcb.2008.06.004 · 2009 · External reference
Development of a biomarker panel for assessing cardiovascular risk in diabetic patients with chronic limb-threatening ischemia (clti): a prospective study
10.1186/s12933-023-01872-x · 2023 · External reference
Elevated serum osteoprotegerin may predict peripheral arterial disease after kidney transplantation: a single-center prospective cross-sectional study in Taiwan
10.7717/peerj.3847 · 2017 · External reference
Serum osteoprotegerin level is positively associated with peripheral artery disease in patients with peritoneal dialysis
10.1080/0886022x.2020.1714654 · 2020 · External reference
Osteoprotegerin concentration is associated with the presence and severity of peripheral arterial disease in type 2 diabetes mellitus
10.1024/0301-1526/a000682 · 2018 · External reference
Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects
10.1186/s12933-017-0581-z · 2017 · External reference
Osteoprotegerin is higher in peripheral arterial disease regardless of glycaemic status
10.1016/j.thromres.2010.09.003 · 2010 · External reference
Targeting sortilin in immune cells reduces proinflammatory cytokines and atherosclerosis
10.1172/jci76002 · 2014 · External reference
Macrophage sortilin promotes ldl uptake, foam cell formation, and atherosclerosis
10.1161/circresaha.116.305811 · 2015 · External reference
D-limonene modulates AMPK signaling to inhibit ox-LDL-induced foam cell formation
10.1038/s41598-025-29351-1 · 2025 · External reference
Molecular mechanisms and therapeutic progress in atherosclerosis: bridging immune inflammation and precision medicine
2025 · External reference
Association between nontraditional lipid profiles and peripheral arterial disease in chinese adults with hypertension
10.1186/s12944-020-01407-3 · 2020 · External reference
Is it possible to predict the complexity of peripheral artery disease with atherogenic index?
10.1177/1708538120923531 · 2020 · External reference
Circulating extracellular vesicles in cardiovascular disease
10.3390/ijms26146817 · 2025 · External reference
Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches
10.1002/jev2.12404 · 2024 · External reference
Extracellular vesicle R-RAS is a potential biomarker for human peripheral artery disease
10.1016/j.isci.2025.113859 · 2025 · External reference
Functional and transcriptomic analysis of extracellular vesicles identifies calprotectin as a new prognostic marker in peripheral arterial disease (PAD)
10.1080/20013078.2020.1729646 · 2020 · External reference
Extracellular vesicles in diabetes mellitus induce alterations in endothelial cell morphology and migration
10.1186/s12967-020-02398-6 · 2020 · External reference
Circulating exosomes from patients with peripheral artery disease influence vascular cell migration and contain distinct microrna cargo
10.1016/j.jvssci.2020.02.001 · 2020 · External reference
Extracellular vesicles and atherosclerotic peripheral arterial disease
10.1016/j.carpath.2022.107510 · 2023 · External reference
Lipocalin-2 and calprotectin potential prognosis biomarkers in peripheral arterial disease
10.1016/j.ejvs.2022.01.012 · 2022 · External reference
Microrna
10.1016/j.jaci.2017.08.034 · 2018 · External reference
MicroRNAs in peripheral artery disease: potential biomarkers and pathophysiological mechanisms
10.1177/17539447221096940 · 2022 · External reference
Dysregulation of microRNA regulatory network in lower extremities arterial disease
10.3389/fgene.2019.01200 · 2019 · External reference
Relationships between indicators of lower extremity artery disease and mirna expression in peripheral blood mononuclear cells
10.3390/jcm11061619 · 2022 · External reference
Mirna regulatory networks associated with peripheral vascular diseases
10.3390/jcm11123470 · 2022 · External reference
MicroRNAs in hyperglycemia induced endothelial cell dysfunction
10.3390/ijms17040518 · 2016 · External reference
Polycystin-1 is a cardiomyocyte mechanosensor that governs l-type ca2+ channel protein stability
10.1161/circulationaha.114.013537 · 2015 · External reference
Molecular mechanosensors in osteocytes
10.1038/s41413-020-0099-y · 2020 · External reference
Polycystin-1 as a novel biomarker for peripheral artery disease: findings from a pilot prospective study
10.1016/j.avsg.2025.07.023 · 2026 · External reference
The prognostic potential of insulin-like growth factor-binding protein 1 for cardiovascular complications in peripheral artery disease
10.3390/jcdd12070253 · 2025 · External reference
Large-scale plasma proteomics improves prediction of peripheral artery disease in individuals with type 2 diabetes: a prospective cohort study
10.2337/dc24-1696 · 2025 · External reference
Negative correlation of serum adiponectin level with peripheral artery occlusive disease in hemodialysis patients
10.4103/tcmj.tcmj_19_19 · 2020 · External reference
Association of adiponectin with peripheral arterial disease and mortality in nondiabetic hemodialysis patients: long-term follow-up data of 7 years
10.4103/1735-1995.184000 · 2016 · External reference
Growth differentiation factor-15 and clinical outcomes in lower extremity artery disease
10.5551/jat.64515 · 2024 · External reference
Prevalence of elevated serum fatty acid synthase in chronic limb-threatening ischemia
10.1038/s41598-021-98479-7 · 2021 · External reference
Abstract 140: plasma interleukin-6 levels and cardiovascular events in the cirt trial: consistent associations for incident coronary, cerebrovascular, and peripheral artery disease
10.1161/atvb.42.suppl_1.140 · 2022 · External reference
Inflammatory-related biomarkers in patients undergoing percutaneous transluminal angioplasty for femoropopliteal artery lesions
2025 · External reference
Variability of the lymphocyte-to-monocyte ratio in patients with chronic kidney disease on hemodialysis
10.1371/journal.pone.0333523 · 2025 · External reference
Prognostic value of lmr and cd163(+)tam for patients with diffuse large b cell lymphoma
2024 · External reference
Predictive values of the selected inflammatory indexes in colon cancer
10.1177/10732748221091333 · 2022 · External reference
Systemic immune-inflammation index and related hematologic markers as prognostic tools in type 2 diabetes
2025 · External reference
Investigation of association between clinically significant prostate cancer, obesity and platelet to-lymphocyte ratio and neutrophil -to-lymphocyte ratio
10.1186/s12894-024-01617-2 · 2024 · External reference
Platelet-to-lymphocyte ratio predicts mortality better than neutrophil-to-lymphocyte ratio in hemodialysis patients
10.1007/s11255-016-1301-4 · 2016 · External reference
Clinical significance of the preoperative platelet count and platelet-to-lymphocyte ratio (plt-plr) in patients with surgically resected non-small cell lung cancer
10.18632/oncotarget.8809 · 2016 · External reference
Association of platelet to lymphocyte ratio (plr) and monocyte to platelet ratio (mpr) with iron status across age and gender groups
10.4103/kkujhs.kkujhs_18_25 · 2025 · External reference
Associations of neutrophil/high-density lipoprotein cholesterol ratio with frailty and its mortality
2024 · External reference
Neutrophil-to-high-density lipoprotein ratio and diminished ovarian reserve in reproductive-aged women: a NHANES perspective
10.1155/adph/9922035 · 2026 · External reference
Correlates of pentraxin 3 serum concentration in men and women with type 2 diabetes
10.1177/1753425919891628 · 2020 · External reference
Pentraxin 3 (ptx3) is associated with severe sepsis and fatal disease in emergency room patients with suspected infection: a prospective cohort study
10.1371/journal.pone.0053661 · 2013 · External reference
Elevated plasma level of pentraxin 3 is associated with emphysema and mortality in smokers
10.1136/thoraxjnl-2020-215356 · 2021 · External reference
The establishment and validation of reference intervals for plasma pentraxin-3 in healthy volunteers and patients with takayasu’s arteritis
10.1016/j.cca.2022.09.028 · 2022 · External reference
The relationship between concentrations of circulating soluble E-selectin and clinical, pathological, and biological features in patients with breast cancer
1998 · External reference
Vascular cell adhesion molecule 1 and e-selectin as potential cardiovascular risk biomarkers in psoriasis
10.3390/ijms26020792 · 2025 · External reference
Serum e-selectin concentration is associated with risk of metabolic syndrome in females
2019 · External reference
Reduced stweak and increased scd163 levels in hiv-infected patients: modulation by antiretroviral treatment, hiv replication and hcv co-infection
10.1371/journal.pone.0090541 · 2014 · External reference
Serum scd163 levels are associated with type 2 diabetes mellitus and are influenced by coffee and wine consumption: results of the di@bet.Es study
10.1371/journal.pone.0101250 · 2014 · External reference
Alterations of soluble tweak and cd163 concentrations in patients with chronic heart failure
10.1016/j.cyto.2016.02.005 · 2016 · External reference
Serum changes in stweak and its scavenger receptor scd163 in ultramarathon athletes running the 24-h race
10.1016/j.cyto.2020.155315 · 2021 · External reference
Factors associated with multiple biomarkers of systemic inflammation
10.1158/1055-9965.epi-15-0956 · 2016 · External reference
Growth differentiation factor 15 may predict mortality of peripheral and coronary artery diseases and correlate with their risk factors
10.1155/2017/9398401 · 2017 · External reference
Superoxide dismutase, catalase and glutathione peroxidase activities in human blood: influence of sex, age and cigarette smoking
10.1016/s0009-9120(97)00047-7 · 1997 · External reference
Serum total antioxidant status, erythrocyte superoxide dismutase and whole-blood glutathione peroxidase activities in the Stanislas cohort: influencing factors and reference intervals
10.1515/cclm.2003.034 · 2003 · External reference
Lipid peroxidation and antioxidant enzymes in turkish population: relation to age, gender, exercise, and smoking
10.1620/tjem.197.119 · 2002 · External reference
Circulating and urinary concentrations of malondialdehyde in aging humans in health and disease: review and discussion
10.3390/biomedicines11102744 · 2023 · External reference
Malondialdehyde serum levels in patients with systemic sclerosis relate to dyslipidemia and low ventricular ejection fraction
2023 · External reference
Increased circulating malondialdehyde-modified ldl levels in patients with coronary artery diseases and their association with peak sizes of ldl particles
10.1161/01.atv.0000012351.63938.84 · 2002 · External reference
Impact of dyslipidemic components of metabolic syndrome, adiponectin levels, and anti-diabetes medications on malondialdehyde-modified low-density lipoprotein levels in statin-treated diabetes patients with coronary artery disease
10.1186/1758-5996-5-77 · 2013 · External reference
Sociodemographic and lifestyle determinants of plasma oxidative stress markers 8-OHdG and F2-isoprostanes and associations with metabolic syndrome
10.1155/2016/7530820 · 2016 · External reference
8-hydroxy-2-deoxyguanosine as oxidative DNA damage biomarker of medical ionizing radiation: a scoping review
10.31661/jbpe.v0i0.2101-1258 · 2021 · External reference
Plasma tetrahydrobiopterin/dihydrobiopterin ratio: a possible marker of endothelial dysfunction
10.1253/circj.cj-08-0850 · 2009 · External reference
Associations of biopterins and adma with vascular function in peripheral microcirculation from patients with chronic kidney disease
10.3390/ijms24065582 · 2023 · External reference
Endothelial dysfunction due to enos uncoupling: molecular mechanisms as potential therapeutic targets
10.1186/s11658-023-00423-2 · 2023 · External reference
Maternal serum heme-oxygenase-1 (ho-1) concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus
10.1371/journal.pone.0048060 · 2012 · External reference
Plasma heme oxygenase-1 concentration in relation to impaired glucose regulation in a non-diabetic chinese population
10.1371/journal.pone.0032223 · 2012 · External reference
Heme oxygenase-1 polymorphisms associate with ischemic cardiac complications and all-cause mortality in type 1 diabetes
10.1186/s12933-025-02895-2 · 2025 · External reference
Plasma heme oxygenase-1 levels in patients with coronary and peripheral artery diseases
10.1155/2018/6138124 · 2018 · External reference
Proteomics profiles of blood glucose-related proteins involved in a Chinese longevity cohort
10.1186/s12014-022-09382-w · 2022 · External reference
Expression of sirt6 and vnn1 in children with primary nephrotic syndrome and their correlation with acute kidney injury
10.62347/touh6376 · 2024 · External reference
Biological determinants of serum icam-1, e-selectin, p-selectin and l-selectin levels in healthy subjects: the stanislas study
10.1016/j.atherosclerosis.2003.11.003 · 2004 · External reference
Heritability and correlates of intercellular adhesion molecule-1 in the Framingham offspring study
10.1016/j.jacc.2004.03.048 · 2004 · External reference
Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men
10.1161/01.cir.0000025636.03561.ee · 2002 · External reference
Associations of vcam-1 gene polymorphisms with obesity and inflammation markers
10.1007/s00011-016-1006-2 · 2017 · External reference
Soluble vascular cell adhesion molecules may be protective of future cardiovascular disease risk: findings from the prevend prospective cohort study
10.5551/jat.38836 · 2017 · External reference
Protein biomarkers and major cardiovascular events in older people with advanced CKD: the European quality (EQUAL) study
10.1016/j.xkme.2023.100745 · 2024 · External reference
Aging and abo blood type influence von willebrand factor and factor viii levels through interrelated mechanisms
10.1111/jth.13294 · 2016 · External reference
Hemoglobin concentration and body mass index are determinants of plasma von willebrand factor and factor viii levels
10.1016/j.thromres.2024.109061 · 2024 · External reference
Rise of levels of von willebrand factor and factor viii with age: role of genetic and acquired risk factors
10.1016/j.thromres.2020.11.016 · 2021 · External reference
Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease
10.1016/j.ejvs.2004.11.001 · 2005 · External reference
Von willebrand factor in patients with peripheral artery disease who undergo invasive treatment
10.17816/pavlovj79099 · 2021 · External reference
Association between matrix metalloproteinase-10 concentration and smoking in individuals without cardiovascular disease
10.1016/s1885-5857(09)60054-2 · 2008 · External reference
Age- and gender-dependent changes in connective tissue remodeling: physiological differences in circulating MMP-3, MMP-10, TIMP-1 and TIMP-2 level
10.1159/000295775 · 2011 · External reference
Role of MMP-1 (−519A/G, −1607 1G/2G), MMP-3 (Lys45Glu), MMP-7 (−181A/G), and MMP-12 (−82A/G) variants and plasma MMP levels on obesity-related phenotypes and microvascular reactivity in a Tunisian population
10.1155/2017/6198526 · 2017 · External reference
The association between serum metalloproteinase concentration, obesity, and hormone levels in reproductive-aged women
10.5603/ep.a2018.0067 · 2019 · External reference
Endothelin-1 serum levels correlate with mcp-1 but not with homocysteine plasma concentration in patients with systemic sclerosis
10.1080/03009740500385584 · 2006 · External reference
Antioxidants modify the relationship between endothelin-1 level and glucose metabolism-associated parameters
10.1016/j.metabol.2009.03.026 · 2009 · External reference
Endothelin-1, cardiac morphology, and heart failure: the mesa angiogenesis study
10.1016/j.healun.2019.07.007 · 2020 · External reference
The causal relationship between endothelin-1 and hypertension: focusing on endothelial dysfunction, arterial stiffness, vascular remodeling, and blood pressure regulation
2021 · External reference
Et-1 as a sex-specific mechanism impacting age-related changes in vascular function
10.3389/fragi.2021.727416 · 2021 · External reference
Comparison of serum levels of endothelin-1 in chronic periodontitis patients before and after treatment
2017 · External reference
Biological sources of variation of serum adiponectin among healthy individuals in comparison with related nutritional and inflammatory markers
10.1016/j.cca.2017.07.014 · 2017 · External reference
Prevalence and risk factors of plasma adiponectin deficiency: a cross-sectional study in a physical examination cohort from Southwest China
10.2147/dmso.s522521 · 2025 · External reference
Identification of influencing variables on adiponectin serum levels in diabetes mellitus type 1 and type 2
10.1055/s-2004-821029 · 2004 · External reference
The influence of sex, body composition, and nonesterified fatty acids on serum adipokine concentrations
10.1016/j.metabol.2009.04.038 · 2009 · External reference
Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patients
10.1530/eje.1.02049 · 2006 · External reference
Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and c-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study
10.1530/eje-07-0797 · 2008 · External reference
Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortality
10.1161/atvbaha.109.199661 · 2010 · External reference
Correlates of osteoprotegerin levels in women and men
10.1007/s001980200045 · 2002 · External reference
Increased serum levels of sortilin are associated with depression and correlated with bdnf and vegf
10.1038/tp.2015.167 · 2015 · External reference
Relation of decreased circulating sortilin levels with unfavorable metabolic profiles in subjects with newly diagnosed type 2 diabetes mellitus
10.1016/j.amjms.2019.10.003 · 2020 · External reference
Serum sortilin levels as a biomarker for metabolic and hormonal dysregulation in polycystic ovary syndrome
10.3390/jpm15020070 · 2025 · External reference
Differences in the triglyceride to hdl-cholesterol ratio between palestinian and israeli adults
10.1371/journal.pone.0116617 · 2015 · External reference
Sex-specific characteristics associated with the elevated triglyceride to high-density lipoprotein cholesterol ratio in a population-based study
10.1016/j.obmed.2019.100151 · 2019 · External reference
Investigation of the predictive values of triglyceride/hdl cholesterol ratio and whole blood viscosity with regard to severe peripheral or carotid artery disease in patients scheduled for coronary bypass
10.1532/hsf.2991 · 2020 · External reference
The association of coffee consumption rate with serum 25-hydroxyvitamin D, non-HDL levels, and TC/HDL ratio in females with vitamin D deficiency
2022 · External reference
Serum concentrations of extracellular fatty acid synthase in patients with steatohepatitis
10.1515/cclm.2009.259 · 2009 · External reference
Circulating serum fatty acid synthase is elevated in patients with diabetes and carotid artery stenosis and is ldl-associated
10.1016/j.atherosclerosis.2019.05.016 · 2019 · External reference
Effect of genetic factors, age and sex on levels of circulating extracellular vesicles and platelets
10.3390/ijms24087183 · 2023 · External reference
Influences of age, race, and sex on extracellular vesicle characteristics
10.7150/thno.72676 · 2022 · External reference
Effects of clinical covariates on serum mirna expression among women without ovarian cancer
10.1158/1055-9965.epi-23-1355 · 2025 · External reference
The importance of standardization on analyzing circulating rna
10.1007/s40291-016-0251-y · 2017 · External reference
Pre-profiling factors influencing serum microrna levels
10.1186/1472-6890-14-27 · 2014 · External reference
The value of concomitant measurement of mir 323b-5p and mir 486-5p with ankle brachial index in diagnosis of peripheral arterial disease
2023 · External reference
A soluble pc-1 circulates in human plasma: relationship with insulin resistance and associated abnormalities
1999 · External reference
Metabolic, anthropometric, and nutritional factors as predictors of circulating insulin-like growth factor binding protein-1 levels in middle-aged and elderly men
10.1210/jc.2003-031349 · 2004 · External reference
